Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study.
Devin AbrahamiRicheek PradhanHui YinRussell YanofskyEmily Gibson McDonaldAlain BittonLaurent AzoulayPublished in: Gut (2023)
Compared with H2RAs, PPIs were not associated with an increased risk of IBD, after accounting for protopathic bias.
Keyphrases